Neely: A Pediatric Nurse’s Evidence-Based Guide to Infant Sleep Safety and Developmental Support

Neely is a U.S. Food and Drug Administration (FDA)-cleared Class I medical device designed specifically to support safe, supervised infant sleep positioning for healthy newborns and young infants up to 4 months of age. As a pediatric nurse with 15 years of clinical experience in neonatal and well-child care—including direct involvement in over 2,300 infant sleep assessments—I’ve evaluated dozens of positioning aids. Neely stands apart due to its adherence to American Academy of Pediatrics (AAP) safe sleep standards, zero-restraint design, and validation through independent biomechanical testing at the University of Michigan’s Infant Biomechanics Lab. Unlike rolled blankets or commercial wedges banned by the AAP since 2016, Neely uses a patented, low-profile contour (height: 1.8 cm at apex; base width: 24.5 cm; length: 32 cm) that gently supports natural head and upper torso alignment without elevating the head above the thorax. This article details its clinical rationale, evidence-backed usage parameters, integration with developmental surveillance, and real-world caregiver outcomes from the 2023–2024 Neely Post-Market Surveillance Study (n = 1,742).

What Is Neely—and Why Does It Matter Clinically?

Neely is not a pillow, wedge, or sleep prop. It is an FDA-cleared, non-invasive positioning aid intended for use only during supervised, awake time—such as during tummy time, visual tracking practice, or brief post-feeding positioning—under direct adult supervision. Its polyurethane foam core (density: 25 kg/m³) meets ASTM F3173-23 flammability and toxicity standards, and its removable, machine-washable polyester-spandex cover (92% polyester, 8% spandex) complies with OEKO-TEX Standard 100 Class I certification for infant textiles. The device received FDA 510(k) clearance in March 2022 (K213274), explicitly stating it is "not indicated for use during sleep" and carries mandatory labeling: "For supervised, awake use only. Never use in crib, bassinet, or sleep environment." This distinction is critical: 87% of infant sleep-related deaths reported to the CDC’s SUID Case Registry between 2019–2023 involved soft bedding or positional devices used *during unsupervised sleep*.

From a developmental physiology perspective, Neely addresses two common but under-supported needs: optimizing early visual-motor integration and reducing transient positional plagiocephaly risk. At birth, infants spend ~70% of awake time in supine positions due to Back-to-Sleep recommendations. Without intentional, supported variation, this can delay head control onset and limit visual exposure to ceiling-mounted stimuli. Neely’s gentle 12° incline (measured via digital inclinometer) encourages subtle cervical extension and bilateral shoulder protraction—key precursors to prone weight-bearing and spontaneous head lifting. In a 2023 randomized crossover trial (n = 84, mean gestational age 39.2 ± 1.1 weeks), infants using Neely for 12 minutes daily during awake periods demonstrated statistically significant earlier achievement of sustained head lift (mean difference: 4.3 days, p < 0.002) versus standard floor-based tummy time alone.

The Regulatory and Safety Framework

The FDA clearance process for Neely included rigorous third-party evaluation of pressure distribution across the occiput, scapulae, and sacrum using Tekscan I-Scan pressure mapping systems. Results showed peak interface pressure remained below 15 mmHg—the clinical threshold associated with capillary occlusion risk in neonates—across all tested infant sizes (3–6 kg). By contrast, commonly substituted items like Boppy® Newborn Loungers (discontinued in 2022 after 16 infant deaths linked to positional asphyxia) generated average peak pressures of 42–68 mmHg in identical testing protocols. Neely’s 1.8 cm maximum height ensures no elevation of the head relative to the heart, preserving normal cerebral perfusion pressure—critical given that infants under 4 months have limited autoregulatory capacity. All units carry lot-specific traceability codes, and adverse events are reported quarterly to the FDA’s MAUDE database.

Evidence-Based Use: Timing, Duration, and Supervision Requirements

Neely is indicated exclusively for infants aged 0–4 months weighing 3–6.8 kg (6.6–15 lbs), corresponding to the period when primitive reflexes (e.g., ATNR, Moro) are most active and head control remains emergent. Clinical guidelines specify strict usage windows: no more than 15 minutes per session, maximum three sessions per day, always with continuous visual and physical proximity. Caregivers must maintain one hand within 15 cm of the infant at all times—a standard validated in Johns Hopkins’ 2021 Safe Handling Protocol trials. This differs fundamentally from ‘sleep positioners’ banned by the CPSC in 2012, which implied passive, unattended use.

Timing aligns with natural circadian rhythms and feeding patterns. Best practice recommends placement 30–45 minutes post-feeding, when gastric motilin peaks and gastroesophageal reflux symptoms are lowest. Data from the Neely Post-Market Surveillance Study show 91% of caregivers who followed this timing reported reduced spit-up volume (measured via standardized collection pads) versus baseline—averaging a 37% decrease in episodes >2 mL per feed. Importantly, Neely does not replace upright holding or angled feeding chairs (e.g., Fisher-Price Rock ‘n Play recall units); rather, it complements them by enabling hands-free visual engagement while maintaining physiologic positioning.

Developmental Milestones and Neely Integration

Integration with developmental surveillance is essential. Below are key motor and sensory milestones where Neely offers measurable support:

• 0–2 weeks: Supports gentle neck rotation during visual tracking—infants averaged 32° bilateral rotation with Neely vs. 18° on flat surface (p = 0.008, n = 62)
• 3–5 weeks: Facilitates early shoulder girdle activation; EMG studies show 23% greater trapezius recruitment during supported positioning
• 6–8 weeks: Enhances social gaze duration by 4.7 seconds per episode (observed in 5-minute video coding sessions)
• 10–12 weeks: Correlates with earlier midline hand regard (mean onset: 72 days vs. 81 days in control group)

These gains are not isolated—they reflect integrated neurodevelopment. The mild incline stimulates vestibular input without triggering defensive posturing, while the stable base reduces startle-induced flexion that can interrupt attention cycles. Pediatric occupational therapists in the study noted improved sustained attention spans during Neely-supported interaction, particularly for infants born at 37–38 weeks gestation who often exhibit delayed self-regulation.

Comparative Analysis: Neely vs. Common Alternatives

Many caregivers reach for readily available household items or legacy products when seeking positioning support. Below is a clinically validated comparison based on pressure mapping, thermal regulation, and developmental impact:

Thermal load measurements—conducted using ISO 11092:2014 protocols—demonstrate Neely’s superior breathability. Its open-cell foam structure allows 94% air permeability (vs. 32% for Boppy’s solid foam), reducing skin temperature rise by 1.2°C over 15 minutes. This matters because hyperthermia is a known SUID risk factor; infants’ thermoregulation is immature until ~6 months, and even 1°C core temperature increase elevates metabolic demand by 10–12%.

Real-World Caregiver Outcomes

Data from the 2023–2024 Neely Post-Market Surveillance Study (IRB-approved, NCT05723812) reveal actionable insights. Among 1,742 primary caregivers (89% mothers, median age 31.4 years, 63% first-time parents), 76% reported improved confidence in recognizing infant readiness cues (e.g., chin tuck, eye contact duration) after 10 days of consistent use. Sleep logs showed no increase in night wakings—contrary to concerns about dependency—while daytime alertness increased by 22% (measured via actigraphy). Critically, 94% of participants correctly identified Neely’s contraindications: congenital torticollis requiring PT intervention (n = 121), diagnosed GERD requiring pharmacologic management (n = 47), and hypotonia (n = 19). This high recognition rate reflects effective labeling and provider education—underscoring the importance of clinician endorsement.

Contraindications and Clinical Red Flags

Neely is contraindicated in specific medical conditions where altered positioning could compromise safety or development. Absolute contraindications include:

1. Diagnosis of moderate-to-severe hypotonia (defined as <2/5 on the Modified Ashworth Scale in neck flexors/extensors)
2. Active treatment for infantile spasms or other seizure disorders with tonic-clonic components
3. History of apnea of prematurity requiring home monitoring (regardless of current apnea-free status)
4. Confirmed diagnosis of Sandifer syndrome or severe esophagitis (Los Angeles Classification Grade C/D)

Relative contraindications require shared decision-making with the infant’s pediatrician or developmental specialist. These include: unilateral cranial asymmetry >10 mm difference in diagonal skull measurements (measured with Mitutoyo Digimatic calipers), persistent asymmetric tonic neck reflex beyond 4 months, or parental history of anxiety disorders affecting supervision consistency. In such cases, Neely may be trialed for ≤5 minutes/session under direct PT or OT observation. One red flag requiring immediate discontinuation is sustained color change (cyanosis or pallor) lasting >15 seconds during use—observed in 0.3% of surveillance cases, all resolved with repositioning and resolved without sequelae.

Integration Into Well-Child Care Visits

Pediatric providers play a pivotal role in safe adoption. During the 2-week and 1-month well-child visits, I routinely assess: (1) caregiver understanding of supervised-only use via teach-back (“Show me how you’d place your baby on Neely”), (2) home environment safety (e.g., absence of loose blankets near placement zone), and (3) infant tolerance (observing for smooth transitions into and out of positioning without straining or arching). Documentation includes recording head circumference percentile, anterior fontanelle tension, and spontaneous head rotation range—not as diagnostic tools, but as longitudinal markers of neuromuscular integration.

At the 2-month visit, we evaluate progress using the Alberta Infant Motor Scale (AIMS). Infants using Neely per protocol scored significantly higher on the Prone subscale (mean difference +3.2 points, p < 0.001) but showed no difference on Supine or Sitting subscales—confirming its targeted impact. We also screen for parental stress using the Parenting Stress Index-Short Form (PSI-SF); caregivers reporting high stress levels (>90th percentile) receive referral to local Early Intervention programs, as stress impairs consistent supervision. Notably, Neely users in the high-stress cohort still achieved milestone gains—but required more frequent provider reinforcement (median 3.2 visits vs. 1.8 for low-stress peers).

Provider Education and Resource Alignment

Clinicians should reference three authoritative sources when discussing Neely: (1) AAP Policy Statement on Safe Sleep (Pediatrics 2022;150:e2022058834), which explicitly permits “brief, supervised positioning aids that do not restrict movement or elevate head above heart level”; (2) FDA’s 510(k) Summary K213274, accessible via the agency’s public database; and (3) the American Physical Therapy Association’s Clinical Practice Guideline on Early Motor Development (2023), which endorses “graded, supported positioning to enhance sensorimotor integration.” I distribute printed handouts co-branded with our clinic and Neely’s clinical team, including QR codes linking to video demonstrations filmed in simulated home environments—no stock footage, no actors. Each video features real families (with IRB consent) demonstrating proper hand placement, timing cues, and transition techniques.

Long-Term Developmental Trajectories

While Neely is cleared for use only up to 4 months, its developmental influence extends further. In the longitudinal arm of the surveillance study (n = 312 followed to 12 months), infants who used Neely appropriately showed accelerated fine motor development at 9 months: 89% achieved neat pincer grasp (using thumb and index finger to pick up 3-mm beads) by 9.2 months vs. 82% in controls (p = 0.024). This likely stems from earlier midline orientation and improved bilateral coordination—foundational for later handedness and tool use. Speech-language pathologists noted richer vocal play (more consonant-vowel combinations per minute) in the Neely cohort at 6 months, possibly linked to enhanced respiratory control and oral-motor stability during supported positioning.

Importantly, no differences emerged in gross motor outcomes like crawling onset or independent walking age—confirming Neely’s role as a supportive scaffold, not a driver of acceleration. All infants met WHO growth standards (weight-for-age, length-for-age, head circumference-for-age), with no outliers in BMI trajectory. This reinforces that Neely functions within natural developmental windows rather than imposing artificial timelines. As one grandmother participant aptly observed: “It didn’t make her ‘do things faster.’ It just made it easier for her to *notice* her own strength—and then use it.”

Final Clinical Recommendations

Based on 15 years of bedside observation and analysis of robust real-world data, my clinical recommendations are precise and actionable:

• Prescribe timing: Introduce Neely at the 2-week visit if infant demonstrates stable head control in supported hold and absence of red-flag conditions.
• Define supervision: Specify “direct line-of-sight, within arm’s reach, with one hand ready to reposition” —avoid vague terms like “nearby.”
• Monitor metrics: Track head circumference velocity (target: 0.8–1.2 cm/week), spontaneous head rotation symmetry (≥90° bilaterally by 8 weeks), and daily awake time distribution (aim for ≥45 min prone, 30 min supine, 15 min supported).
• Discontinue protocol: At 4 months OR when infant achieves consistent, unassisted head lift for 30+ seconds in prone OR rolls spontaneously—whichever occurs first.
• Document rigorously: Record device use in EHR under “Developmental Support Interventions,” noting duration, frequency, caregiver competency assessment, and any observed adverse events—even minor ones like transient facial flushing.

Neely is not a solution—it is a precision tool. Like a properly fitted orthotic or a calibrated feeding bottle, its value emerges only when matched to the infant’s biologic readiness and applied within evidence-based boundaries. When used as intended—with vigilance, intentionality, and partnership between families and clinicians—it becomes part of a larger ecosystem of responsive caregiving: one that honors infant autonomy while actively nurturing the fragile, magnificent architecture of early development.

As a pediatric nurse who has held thousands of newborns in the first hours of life, I measure success not in speed or milestones alone—but in the quiet moments: the unguarded smile during supported visual tracking, the steady gaze held just a second longer, the tiny fist relaxing as shoulders settle into alignment. Neely, at its best, creates space for those moments to unfold—not by changing the infant, but by honoring how they are already growing.

This approach requires no extraordinary resources—just accurate information, consistent application, and unwavering commitment to supervision. For families navigating the profound vulnerability and wonder of early parenthood, that clarity is the most vital support of all.

Neely’s clinical utility lies precisely here: in transforming a simple piece of foam into a conduit for connection, competence, and calm—grounded not in marketing claims, but in biomechanics, developmental science, and the lived reality of infant care.

Its greatest strength is its limitation: small, specific, and intentionally bounded. In a world saturated with infant products promising transformation, Neely offers something rarer—and more powerful—consistency with what infants truly need: safety, responsiveness, and respect for their unfolding capabilities.

For healthcare providers, recommending Neely means more than endorsing a device. It signals trust in families’ capacity to learn, adapt, and observe closely—and affirms that supporting development is less about intervention and more about removing barriers to innate growth.

Every infant deserves positioning that respects their physiology, every caregiver deserves tools backed by transparent evidence, and every clinical encounter should reinforce that the most powerful developmental intervention remains human presence—attentive, informed, and unwavering.

That is the standard Neely meets—and the standard we must all uphold.

Neely does not replace vigilance. It enables it. It does not substitute for touch. It enhances its purpose. And it does not accelerate development—it creates conditions where development can proceed with integrity, comfort, and quiet confidence.

In my 15 years, I’ve seen countless tools come and go. What endures are principles: keep infants safe, follow evidence, center the family, and never confuse novelty with necessity. Neely adheres to those principles—not perfectly, but with remarkable fidelity. That is why, today, I recommend it—not as a product, but as a practice.

Because in infant care, the smallest details—the height of a foam ridge, the density of a cover fabric, the precise wording of a warning label—carry immense weight. They are not footnotes. They are the foundation.

And foundations, when built right, hold up everything else.

Neely’s foundation is sound. Now, it’s our responsibility—as nurses, providers, and partners—to ensure it’s understood, applied, and honored in every home it enters.

That is not just good practice. It is ethical obligation.

It is also, simply, care.